An HPLC-ESI–MS/MS method was applied to investigate the changes in sphingolipids.
Arsenic trioxide (As2O3) was used to treat human U266 and MGC-803 cells.
The distributions of sphingolipids are different in the human U266 and MGC-803 cells.
The levels of Hex2Cer in human U266 cells decreased when treated with As2O3.
The levels of S1P and dhS1P in human MGC-803 cells decreased when treated with As2O3.